1. P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AND CYTOKINE-RELEASE SYNDROME AFTER CD19 CAR-T CELL THERAPY - A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART COALITION. (23rd June 2022) Authors: Basak, G.; Peczynski, C.; Koenecke, C.; Terwel, S.; Cabrerizo, Y.; Penack, O.; Moiseev, I.; Schoemans, H.; Fegueux, N.; Potter, V.; Zeerleder, S.; Yakoub-Agha, I.; Collin, M.; Schanz, U.; Dreger, P.; Blaise, D.; Besley, C.; Glass, B.; Mohty, M.; Chabannon, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: INDUCTION CHEMOTHERAPY AND ECULIZUMAB TREATMENT OF HIGH-RISK MYELODYSPLASIA WITH A LARGE PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA CLONE. (September 2021) Authors: Cross, J.; Johansson, U.; Besley, C.; Protheroe, R.; Kulasekararaj, A.; Mehta, P. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗